Related Experiment Video
Updated: Mar 6, 2026

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions
Published on: June 7, 2020
Immunodominant protein MIP_05962 from Mycobacterium indicus pranii displays chaperone activity
Ashish Sharma1, Md Javed Equbal1, Saurabh Pandey2
1Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, India.
Abstract:
Tuberculosis, a contagious disease of infectious origin is currently a major cause of deaths worldwide. Mycobacterium indicus pranii (MIP), a saprophytic nonpathogen and a potent immunomodulator is currently being investigated as an intervention against tuberculosis along with many other diseases with positive outcome. The apparent paradox of multiple chaperones in mycobacterial species and enigma about the cellular functions of the client proteins of these chaperones need to be explored. Chaperones are the known immunomodulators; thus, there is need to exploit the proteome of MIP for identification and characterization of putative chaperones. One of the immunogenic proteins, MIP_05962 is a member of heat shock protein (HSP) 20 family due to the presence of α-crystallin domain, and has amino acid similarity with Mycobacterium lepraeHSP18 protein. The diverse functions of M. lepraeHSP18 in stress conditions implicate MIP_05962 as an important protein that needs to be explored. Biophysical and biochemical characterization of the said protein proved it to be a chaperone. The observations of aggregation prevention and refolding of substrate proteins in the presence of MIP_05962 along with interaction with non-native proteins, surface hydrophobicity, formation of large oligomers, in-vivo thermal rescue of Escherichia coli expressing MIP_05962, enhancing solubility of insoluble protein maltodextrin glucosidase (MalZ) under in-vivo conditions, and thermal stability and reversibility confirmed MIP_05962 as a molecular chaperone.
Insights
Mycobacterium indicus pranii (MIP) protein MIP_05962, a heat shock protein, functions as a molecular chaperone. It prevents protein aggregation and aids in refolding, offering potential therapeutic applications against diseases like tuberculosis.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Tuberculosis remains a leading cause of global mortality.
- Mycobacterium indicus pranii (MIP) shows promise as an immunomodulator for tuberculosis treatment.
- The roles of mycobacterial chaperones and their client proteins require further investigation.
Purpose of the Study:
- To identify and characterize potential chaperones within the MIP proteome.
- To investigate the function of MIP_05962, an immunogenic heat shock protein 20 family member.
- To explore the molecular chaperone activity of MIP_05962.
Main Methods:
- Biophysical and biochemical characterization of MIP_05962.
- Assays for protein aggregation prevention and substrate protein refolding.
- Analysis of protein interactions, surface hydrophobicity, and oligomer formation.
- In vivo studies including thermal rescue of E. coli and solubility enhancement of MalZ.
Main Results:
- MIP_05962 demonstrated molecular chaperone activity.
- The protein prevented aggregation and facilitated refolding of substrate proteins.
- MIP_05962 interacted with non-native proteins, exhibited surface hydrophobicity, and formed large oligomers.
- In vivo experiments confirmed its ability to provide thermal protection and enhance protein solubility.
Conclusions:
- MIP_05962 is confirmed as a functional molecular chaperone.
- Its properties suggest potential as a therapeutic agent, particularly in combating protein misfolding-related diseases.
- Further research into MIP_05962 could elucidate novel intervention strategies for tuberculosis and other conditions.
Related Concept Videos
Bacterial Protein Maturation
Molecular Chaperones and Protein Folding
The...
Molecular Chaperones and Protein Folding

